Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia
Public ClinicalTrials.gov record NCT03482440. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Role of Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclamptic Pregnancy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Women who develop preeclampsia during pregnancy are more likely to develop cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs is unclear but may be related to blood vessel damage and increased inflammation that occurs during the preeclamptic pregnancy and persists postpartum. The purpose of this investigation is to 1) determine the mechanisms contributing to this lasting blood vessel damage and chronic inflammation, and to 2) identify factors (both physiological and pharmacological) that mitigate these negative effects in order to inform better clinical management of cardiovascular disease risk in women who have had preeclampsia.
Study identification
- NCT ID
- NCT03482440
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Early Phase 1
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 25, 2018
- Primary completion
- Jul 10, 2019
- Completion
- Dec 30, 2022
- Last update posted
- Jun 2, 2025
2018 – 2022
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Pennsylvania State University | University Park | Pennsylvania | 16802 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Preeclampsia trials
Other public records listing Preeclampsia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07778966: Community Health Worker Support to Lower Blood Pressure After a Pregnancy With High Blood Pressure Not yet recruiting
- NCT07448597: Progesterone Preeclampsia Recruiting
- NCT07222852: Cardiovascular Protection After Preeclampsia With Enalapril Recruiting
- NCT07715669: Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia Recruiting
- NCT07218237: Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy Recruiting
- NCT04154332: Exosome Cargo From Preeclampsia Patients Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03482440, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2025 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03482440 live on ClinicalTrials.gov.